Chapter 7: Handling Publications, Patents, Peer Review, and Regulatory Claims
Research papers, patents, conference presentations, and regulatory milestones can provide important evidence of scientific achievement. However, each represents a different type and stage of accomplishment. A credible business award nomination should describe these materials precisely and avoid implying that they prove more than they actually establish.
Scientists from all over the world may explore relevant Globee Awards opportunities. The Globee Awards are business awards, not academic journals, patent authorities, licensing bodies, or regulatory agencies. Recognition concerns an eligible achievement evaluated under the rules of the applicable awards program. It does not convert preliminary research into accepted science, grant intellectual-property rights, or provide regulatory authorization.
Describe Publication Status Accurately
When referring to scientific research, nominees should identify its publication status clearly. Research materials may include:
- Articles published in peer-reviewed journals
- Accepted manuscripts awaiting publication
- Preprints that have not completed peer review
- Conference papers, abstracts, posters, or presentations
- Dissertations or university research
- Internal scientific or technical reports
- White papers
- Government or institutional reports
- Promotional articles or company-produced content
These materials should not be treated as interchangeable.
A peer-reviewed paper has been evaluated under the procedures of the journal that published it. That status may support the credibility of the research, but it does not mean that every conclusion is universally accepted or that the work has produced practical, organizational, medical, environmental, societal, or commercial impact.
A preprint makes research publicly available before formal peer review and should be identified as a preprint. Conference materials may communicate valuable findings, but their review processes can vary. An internal report may contain useful evidence, although it should not be described as independently published research. Promotional content may explain a product or achievement, but it is not independent scientific validation.
Scientists should also avoid describing research as “published” when it has only been submitted to a journal. Appropriate terms might include “submitted,” “under review,” “accepted,” “available as a preprint,” or “published in a peer-reviewed journal,” depending on the actual status.
Publication Does Not Automatically Prove Impact
Publishing research can be an important accomplishment, but publication alone does not necessarily demonstrate that the findings have been implemented or produced measurable benefits.
A paper may present a promising laboratory result without showing that the approach works in a wider setting. It may contribute to scientific understanding without producing an immediate product, process, treatment, or organizational improvement. It may also require replication, additional testing, clinical evaluation, regulatory review, or further development.
If a nomination claims that published research led to practical results, the connection should be supported by evidence. The scientist might explain that the research informed an implemented process, supported the development of a product, improved laboratory performance, influenced an organizational decision, or contributed to a measurable environmental or community outcome. The nomination should distinguish these demonstrated results from anticipated future applications.
Explain Patents Precisely
A patent may be relevant evidence of invention and intellectual property, but its status must be stated accurately.
A patent application is not the same as a granted patent. A provisional application, pending application, published application, and issued patent represent different stages. Nominees should identify the appropriate patent authority, patent status, inventor or inventors, owner or assignee, and connection to the achievement when relevant.
A scientist should also distinguish inventorship from ownership. The inventor may be an individual or group, while the patent may belong to an employer, university, research institution, or another organization.
A patent does not automatically prove:
- Commercial success
- Market adoption
- Product availability
- Regulatory approval
- Scientific superiority
- Safety or effectiveness
- Practical implementation
- Revenue or customer demand
- Broad societal impact
If a patented invention has produced measurable results, those results should be documented separately. For example, the nomination might provide authorized evidence of implementation, licensing, manufacturing, adoption, performance improvements, or another relevant outcome.
Use Careful Language for Regulated Claims
Medical, pharmaceutical, biotechnology, environmental, safety, energy, agricultural, and other regulated fields require particularly careful wording. An award nomination should never imply that a product, treatment, device, process, or scientific claim has received regulatory approval when it has not.
Terms such as “approved,” “authorized,” “cleared,” “certified,” “clinically validated,” “safe,” “effective,” or “compliant” may have specific legal or regulatory meanings. Scientists should use these terms only when the applicable status is accurate, current, and supported by authoritative evidence.
For example, a laboratory finding should not be described as an approved treatment. A clinical study should not be presented as proof of universal effectiveness. A regulatory submission should not be called regulatory approval. Early safety testing should not be represented as conclusive proof that a product is safe in every intended setting.
Where authorization has been granted, the nomination should identify the relevant authority, jurisdiction, approved use, and date when appropriate. Approval in one country should not be presented as worldwide approval. Authorization for one purpose should not be expanded to suggest approval for unrelated uses.
Avoid Implying Scientific Consensus
Scientific knowledge develops through testing, review, replication, criticism, and continued investigation. An award nomination should not suggest that recognition by a business awards program establishes scientific consensus.
Claims such as “scientifically proven,” “universally accepted,” “completely safe,” “guaranteed to work,” or “the only effective solution” require exceptionally strong support and may still be inappropriate when evidence remains limited or disputed.
More precise language strengthens credibility. A nomination can state what a study found, what conditions were tested, what limitations remain, and what results have been independently verified. It should separate the nominee’s conclusions from findings established by outside authorities.
Present the Achievement Responsibly
Before submission, scientists should verify publication citations, patent numbers, regulatory descriptions, dates, authorship, inventorship, and approval status. They should obtain permission before sharing confidential research, restricted regulatory information, unpublished intellectual property, patient information, or materials owned by another party.
Providing publications, patents, peer-review records, or regulatory documents does not guarantee eligibility, a particular score, or recognition. These materials help support relevant claims, but the achievement must still fit a current Globee Awards program and category.
Explore Relevant Globee Awards Opportunities
Scientists from all countries may explore current Globee Awards programs, categories, eligibility requirements, and potential nomination opportunities at GlobeeAwards.com.
Before submitting, confirm that the achievement fits the selected business award category and that all publication, patent, peer-review, and regulatory claims are accurate, appropriately attributed, authorized, and supported by credible evidence.